Plakous Therapeutics, a Winston-Salem, NC-based biotherapeutic company, raised $310K in funding.
North Carolina Biotechnology Center provided the funding.
The company intends to use the funds for ongoing development and marketing of Protego-PD™, its regenerative medicine first product.
Led by CEO Robert Boyce, Plakous Therapeutics develops placenta derived regenerative therapies that improve patient outcomes and reduce health care costs.
